[ad_1]
The US biotech company Regeneron’s COVID-19 antibody treatment has been approved for emergency use by the US Food and Drug Administration and the FDA.
According to local media, the FDA has approved the emergency use of Regeneron’s antibody treatment.
The FDA has approved the urgent use of Regeneron antibody therapy to treat patients 12 years of age and older with mild or moderate symptoms.
The drug was used in the treatment of COVID-19 by US President Donald Trump and garnered public attention.
Yonhap News TV article inquiries and reports: katok / line jebo23
Unauthorized reproduction – prohibition of redistribution>
22/11/2020 13:18 sent
Source link
